CSCs are commonly associated with a specific set of surface antigens, such as CD34+CD38− for AML, CD133+, CD44+, and other antigens for solid tumors, based on their ability to initiate tumors in nude and NOD/SCID mice [18]. This evidence concerns the gene CD44 and acute myeloid leukemia.